METTLER TOLEDO INTERNATIONAL INC/ MTD
METTLER TOLEDO INTERNATIONAL INC/ is a laboratory analytical instruments issuer listed as MTD on NYSE. This free Atlas page links SEC CIK 1037646, Nasdaq Trader and TradingView NYSE:MTD, related symbols and the workstation route before a full report is run.
MTD public profile
Laboratory analytical instruments issuer. Atlas tracks MTD through its NYSE listing record, chart route and source links.
MTD trades on NYSE. SEC CIK 1037646. Chart route NYSE:MTD.
Nasdaq Trader is the listing identity source for METTLER TOLEDO INTERNATIONAL INC/. Atlas files MTD under USA Stocks for browsing. The canonical public URL is /stocks/MTD/. The workstation link below opens the fuller research run.
Market Wit preview
Mettler-Toledo's 10-Q for the quarter ending March 31, 2026 shows a company that can sell weighing machines and lab gear like it's flogging fresh bread at a bakery, but its balance sheet is reading the small print: shareholders' equity clocks in at minus $41.9 million, while liabilities are running $3.71 billion against $3.67 billion in assets. Imagine a restaurant that bakes perfect sourdough but keeps the receipts in a shoebox under a wobbly table leg; that's the optics here. Meanwhile, the industrial division, which makes up about 40% of sales, grew 10% in dollars and 5% in local currencies, with food retailing and product inspection doing the heavy lifting, while core-industrial and lab products were stuck in the slow lane. (source: MTD SEC EDGAR...
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for MTD.
What changed for METTLER TOLEDO INTERNATIONAL INC/ today
Mettler-Toledo International Inc. filed its latest 10-Q on May 8, 2026, and the numbers reveal a company that knows how to weigh things but is struggling to balance its own books. Revenue for the quarter ending March 31, 2026 came in at $947.1 million, up from the same period last year, while net income attributable to the parent was $169.5 million. But the headline hides a balance sheet that is, at best, creatively financed: shareholders’ equity stands at minus $41.9 million, with total liabilities at $3.71 billion against $3.67 billion in assets. The company’s cash balance, meanwhile, is a modest $69.1 million, which is less than the cost of a single modern weighing system for a large pharmaceutical plant.
What does Mettler-Toledo actually do? It sells precision instruments-weighing systems, lab equipment, and product inspection gear-used in industries from food retailing to pharmaceuticals and industrial manufacturing. The company splits its sales roughly 40% industrial products and services, 30% laboratory products, and 30% retail and food. For the quarter, net sales in industrial products and services rose 10% in dollars and 5% in local currencies, driven by strong growth in food retailing and product inspection, while core-industrial and laboratory products posted modest declines. The company’s ability to pivot toward high-growth niches like food retailing and product inspection is a sign of adaptability, but it also signals that the broader industrial and lab markets aren’t firing on all cylinders yet.
The 10-Q shows revenues of $947.1 million, net income of $169.5 million, and diluted EPS of $8.33 on 20.3 million diluted shares. Cash from operations was $139.8 million, but the company spent $17.4 million on property, plant, and equipment and saw inventories climb by $19.9 million to $404.8 million. Research and development expense was $51.3 million, reflecting continued investment in new products. The balance sheet’s equity deficit and the thin cash balance are the most striking features of this filing, and they underscore the tension between operational strength and financial structure.
For a live view of how the market is processing these numbers, see Mettler-Toledo’s filings and submissions on the SEC EDGAR index, where the company’s latest documents-including 8-Ks, 10-Qs, and Form 4s-are updated in real time. The SEC submissions JSON feed provides a structured snapshot of the company’s regulatory activity, while the companyfacts JSON offers a deeper dive into the XBRL data behind the filings. If you’re looking for the raw mechanics of how these filings move through the system, the EDGAR index is the best place to start.
The quarter’s numbers suggest Mettler-Toledo is executing well in its chosen niches but is still working to repair a balance sheet that is, at best, unconventional. The company’s growth in food retailing and product inspection is encouraging, but the broader industrial and lab markets remain soft, and the thin cash balance limits its financial flexibility. Investors will want to see whether the company can convert its operational strengths into a more conventional capital structure-or whether the equity deficit becomes a permanent feature of the story. The next catalyst is likely the next 10-Q or 8-K, where the company will either address the balance sheet or double down on the narrative that ‘this time, the numbers will tell a different story.’
What remains unproven is whether Mettler-Toledo’s growth in food retailing and product inspection can offset the softness in core-industrial and laboratory products over the medium term. The company’s R&D spend is healthy, but the cash balance is thin, and the equity deficit is a red flag that the market is unlikely to ignore. The company’s ability to generate free cash flow and reduce leverage will be the key tests in the coming quarters. Evidence that can’t be fudged includes a sustained recovery in core-industrial and lab demand, a reduction in inventories, and a balance sheet that stops reading like a creative accounting exercise.
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Atlas has no approved static OHLC cache attached for MTD yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.
Run an Atlas research workflow on MTD
FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.
Open Atlas workstation ->Save MTD research and exports
Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
MTD FAQ
What is METTLER TOLEDO INTERNATIONAL INC/ (MTD)?METTLER TOLEDO INTERNATIONAL INC/ is a laboratory analytical instruments issuer listed as MTD on NYSE. This free Atlas page links SEC CIK 1037646, Nasdaq Trader and...
METTLER TOLEDO INTERNATIONAL INC/ is a laboratory analytical instruments issuer listed as MTD on NYSE. This free Atlas page links SEC CIK 1037646, Nasdaq Trader and TradingView NYSE:MTD, related symbols and the workstation route before a full report is run.
What does Atlas show for MTD?The MTD page gives the free Atlas profile for METTLER TOLEDO INTERNATIONAL INC/: listing identity, chart route, related symbols, source authority and the workstation...
The MTD page gives the free Atlas profile for METTLER TOLEDO INTERNATIONAL INC/: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NYSE:MTD; the stable page route is /stocks/MTD/. Visible source links include SEC EDGAR CIK 1037646, Nasdaq Trader and TradingView NYSE:MTD. Atlas files MTD under USA Stocks for browsing.
How often is the MTD page updated?The /stocks/MTD/ URL is stable. Atlas updates the free MTD page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...
The /stocks/MTD/ URL is stable. Atlas updates the free MTD page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.
Which sources does Atlas use for MTD?For MTD, Atlas starts with SEC EDGAR CIK 1037646, Nasdaq Trader and TradingView NYSE:MTD. The SEC CIK 1037646 route is the issuer filing anchor. Nasdaq Trader confirms...
For MTD, Atlas starts with SEC EDGAR CIK 1037646, Nasdaq Trader and TradingView NYSE:MTD. The SEC CIK 1037646 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NYSE:MTD is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.
Can Atlas run a full research brief on MTD?Yes. The workstation can open MTD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open MTD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this MTD page investment advice?No. The MTD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...
No. The MTD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-06-20. Browse FreedomCore Atlas research notes →